Stryker entered into a definitive agreement to acquire Instratek, provider of implants and minimally invasive soft tissue recession instrumentation for foot, ankle and upper extremity procedures.
Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by the end of 2016.
Lattice Biologics closed a private placement for gross proceeds of up to US $0.75MM to fund M&A and the acquisition of donors to support production of an amniotic fluid product for regenerative use. The novel regenerative therapeutic will target osteoarthritis, spine, sports-medicine, foot/ankle and other indications.Â
Vertebral Technologies entered into a strategic partnership with BioMedical Technologies International to distribute InterFuse S™ and T™ spinal fusion devices throughout Mexico.